Characterization of a new SUMO-1 nuclear body (SNB) enriched in pCREB, CBP, c-Jun in neuron-like UR61 cells

Chromosoma

Volumn 116, Issue 5, 2007, Pages 441-451

  Navascués, Joaquín ^b   Bengoechea, Rocio ^a   Tapia, Olga ^a   Vaqué, José P ^a   Lafarga, Miguel ^a,c   Berciano, Maria T ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN C JUN; SUMO 1 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS INCLUSION BODY; CELL SURVIVAL; COILED BODY; CONJUGATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; MOUSE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; ONCOGENE N RAS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION;

ANIMALS; CELL NUCLEOLUS; CELLS, CULTURED; CREB-BINDING PROTEIN; DEXAMETHASONE; GENE EXPRESSION REGULATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PC12 CELLS; RATS; SUMO-1 PROTEIN;

EID: 34648823175     PISSN: 00095915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00412-007-0107-7     Document Type: Article

References (53)

1. Berciano MT, Novell M, Villagra NT, Casafont I, Bengoechea R, Val-Bernal F, Lafarga M (2007) Cajal body number and nucleolar size correlate with cell body mass in human sensory ganglia neurons. J Struct Biol 158:410-420
2. Boggio R, Colombo R, Hay RT, Draetta GF, Chiocca S (2004) A mechanism for inhibiting the SUMO pathway. Mol Cell 19:549-561
3. Bohmann K, Ferreira J, Lamond AI (1995) Mutational analysis of p80 coilin indicates a functional interaction between coiled bodies and nucleolus. J Cell Biol 68:817-831
4. Boisvert FM, Hendzel MJ, Bazzett-Jones D (2000) Promyelocytic leukaemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148:283-292
5. Chan HM, La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114:2363-2373
6. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy RR, Goodman RH (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859
7. Cioce M, Lamond AI (2005) Cajal Bodies: A long history of discovery. Annu Rev Cell Dev Biol 21:105-131
8. Comerford KM, Leonard MO, Karhausen J, Carey R, Colgan SP, Taylor CT (2003) Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci USA 100:986-991
9. David G, Neptune MA, DePinho RA (2002) SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 277:1867-1871
10. Desterro JM, Thomson J, Hay RT (1997) Ubc9 conjugates SUMO but not ubiquitin. FEBS Lett 417:297-300
11. Desterro JM, Rodriguez MS, Hay RT (1998) SUMO-1 modification of IkappaB-alpha inhibits NF-kappaB activation. Mol Cell 2:233-239
12. Desterro JM, Keegan LP, Jaffray E, Hay RT, O'Connell MA, Carmo-Fonseca M (2005) SUMO-1 modification alters ADAR1 editing activity. Mol Biol Cell 16:5115-5126
13. Dohmen RJ (2004) SUMO protein modification. Biochim Biophys Acta 29:113-131
14. Gill G (2004) SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev 18:2046-2059
15. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18:6462-6471
16. Grande MA, van der Kraan I, van Steensel B, Schul W, de Thé H, van der Voort HTM, de Jong L, van Driel R (1996) PML-containing nuclear bodies: Their spatial distribution in relation to other nuclear components. J Cell Biochem 63:280-291
17. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochomocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428
18. Guerrero I, Pellicer A, Burstein DE (1988) Dissociation of c-Fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-Ras oncogene. Biochem Biophys Res 150:1185-1192
19. Hagerty T, Morgan WW, Elango N, Strong R (2001) Identification of a glucorticoid-responsive element in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 76:825-883
20. Hay RT (2005) SUMO: A history of modification. Mol Cell 18:1-12
21. Hochstrasser M (2001) SP-RING for SUMO: New functions bloom for an ubiquitin-like protein. Cell 107:5-8
22. Hofmann TG, Will H (2003) Body language: The function of PML nuclear bodies in apoptosis regulation. Cell Death Differ 10:1290-1299
23. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ETH, Strauss JF III, Maul GG (1999) PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:212-233
24. Kamitani T, Nguyen HP, Yeh ETH (1997) Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem 272:14001-14004
25. Korzus E, Rosenfeld MG, Mayford M (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42:961-972
26. Leppa S, Eriksson M, Saffrich R, Ansorg W, Bohmann D (2001) Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol Cell Biol 21:4369-4378
27. Lieberman AP (2004) SUMO, an ubiquitin-like modifier implicated in neurodegeneration. Exp Neurol 185:204-207
28. Lonze BE, Ginty DD (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-623
29. Lonze BE, Riccio A, Cohen S, Ginty DD (2002) Apoptosis, axonal growth defects and degeneration of peripheral neurons in mice lacking CREB. Neuron 34:371-385
30. Melchior F (2000) SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 16:591-626
31. Müller S, Berger M, Lehembre F, Séller JS, Haupt Y, Dejean A (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275:13321-13329
32. Navascues J, Berciano MT, Tücker KE, Lafarga M, Matera G (2004) Targeting SMN to Cajal bodies and nuclear gems during neuritogenesis. Chromosoma 112:398-409
33. Pena E, Berciano MT, Fernandez R, Ojeda JL, Lafarga M (2001) Neuronal body size correlates with the number of nucleoli and Cajal bodies, and with the organization of the splicing machinery in rat trigeminal ganglion neurons. J Comp Neurol 430:250-263
34. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533
35. Pountney DL, Huang Y, Burns RJ, Haan E, Thompson PD, Blumbergs PC, Gai WP (2003) SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol 184:436-446
36. Reimer G, Pollard KM, Penning CA, Ochs RL, Lischwe NA, Tan EM (1987) Monoclonal antibody from (New Zealand Black × New Zealand White) F1 mouse and some human scleroderma sera target a Mr 34000 nucleolar protein of the U3-ribonucleoprotein particle. Arthritis Rheum 30:793-800
37. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, Sendtner M (2003) SMN, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons. J Cell Biol 163:801-812
38. Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL (2003) Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22:6537-6549
39. Schimidt D, Muller S (2002) Members of the PIAS family act as SUMO ligases for c-Jun and P53 and repress p53 activity. Proc Natl Acad Sci U S A 99:2872-2877
40. Seeler JS, Dejean A (2001) SUMO: Of branched proteins and nuclear bodies. Oncogene 20:7243-7249
41. Seeler JS, Dejean A (2003) Nuclear and unclear functions of SUMO. Nature Reviews Mol Cell Biol 4:690-699
42. Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24:331-339
43. Shiio Y, Eisenman RN (2003) Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100:13225-13230
44. Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H (2006) SUMOylation substrates in neuronal intranuclear inclusion disease. Neuropathol Appl Neurobiol 32:92-100
45. Tavanez JP, Calado P, Braga J, Lafarga M, Carmo-Fonseca M (2005) In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA 11:752-762
46. Vaudry D, Stork JS, Lazarovici P, Eiden LE (2002) Signaling pathways for PC12 cell differentiation: Making the right connections. Science 296:1648-1649
47. Verger I, Perdomo J, Crossley M (2003) Modification with SUMO. A role in transcriptional regulation. EMBO Reports 4:137-142
48. Villagra NT, Berciano J, Altable M, Navascues J, Casafont I, Lafarga M, Berciano MT (2004) PML bodies in reactive sensory ganglion neurons of the Guillain-Barré syndrome. Neurobiol Dis 16:158-168
49. Villagra NT, Navascues J, Val-Bernal F, Lafarga M, Berciano MT (2006) The PML nuclear inclusion of human supraoptic neurons: A new compartment with SUMO-1 and ubiquitin-proteasome associated domains. Neurobiol Dis 21:181-193
50. Vo N, Goodman RH (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505-13508
51. Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S, Takahashi H (2001) Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 159:1785-1795
52. Zhang H, Xing L, Rossoll W, Wichterle H, Singer RH, Bassell GJ (2006) Multiprotein complexes of the survival of motor neuron protein SMN with gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci 26:8622-8632
53. Zhong S, Müller S, Ronchetti S, Freemont PS, Dejan A, Pandolfi PP (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748-2752